Correlation Between Boeing and Cannara Biotech

Can any of the company-specific risk be diversified away by investing in both Boeing and Cannara Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Boeing and Cannara Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between The Boeing and Cannara Biotech, you can compare the effects of market volatilities on Boeing and Cannara Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Boeing with a short position of Cannara Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Boeing and Cannara Biotech.

Diversification Opportunities for Boeing and Cannara Biotech

0.54

Correlation Coefficient

Boeing  Cannara Biotech

Very weak diversification

The 3 months correlation between Boeing and Cannara is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding The Boeing and Cannara Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cannara Biotech and Boeing is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on The Boeing are associated (or correlated) with Cannara Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cannara Biotech has no effect on the direction of Boeing i.e., Boeing and Cannara Biotech go up and down completely randomly.

Pair Corralation between Boeing and Cannara Biotech

Allowing for the 90-day total investment horizon The Boeing is expected to generate 0.32 times more return on investment than Cannara Biotech. However, The Boeing is 3.08 times less risky than Cannara Biotech. It trades about 0.02 of its potential returns per unit of risk. Cannara Biotech is currently generating about -0.01 per unit of risk. If you would invest  16,277  in The Boeing on September 12, 2024 and sell it today you would earn a total of  133.00  from holding The Boeing or generate 0.82% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

The Boeing  vs.  Cannara Biotech

Boeing

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in The Boeing are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Boeing is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Cannara Biotech

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cannara Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical and fundamental indicators, Cannara Biotech is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Boeing and Cannara Biotech

The main advantage of trading using opposite Boeing and Cannara Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Boeing position performs unexpectedly, Cannara Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cannara Biotech will offset losses from the drop in Cannara Biotech's long position.

The idea behind The Boeing and Cannara Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.